ARTIS Ventures
Overview
ARTIS Ventures is a venture capital investment firm founded in 2001. The firm seeks to invest in companies operating in artificial intelligence, machine learning, quantum computing, smart data, engineering, diagnostics, targeted therapeutics, medical devices, and wellness sectors. As an early leader in the emerging TechBio sector, ARTIS Ventures funds companies at the intersection of computer science and life science, applying engineering principles and data-enabled discovery to healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Arkenstone Defense | Jul 2026 | Seed | Co-investor |
| Onto Health | Apr 2026 | Series A | Lead |
| Unnatural Products | Mar 2026 | Series B | Co-investor |
| Luminate Medical | Jan 2026 | Series A Extension | Lead |
| Affect Therapeutics | Nov 2025 | Series B | Co-investor |
Key People
Stuart Peterson
Managing Partner
Austin Walne
Senior Partner
Paul Johnson 🇬🇧🇺🇸
Operating Partner
Jeff Sheedy
Partner
Niraj Mehta
Partner
Alexander Real
Principal
Henry Klingenstein
Investor
Arun Rai
Venture Capital Ambassador
Benjamin Meyer
Fellow, TechBio Venture Capital
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
